< Back to previous page
Researcher
Patrik Verstreken
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Neurological and neuromuscular diseases
- See also: Patrik Verstreken (Flanders Institute for Biotechnology)
Affiliations
- Research Group Molecular Neurobiology (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2017 → Today - Laboratory of Neuronal Communication (VIB-KU Leuven) (Lab)
Responsible
From1 Jan 2008 → Today - Laboratory of Neuronal Communication (VIB-KU Leuven) (Lab)
Member
From1 Jan 2017 → Today - VIB-KU Leuven Center for Brain & Disease Research (Research Center)
Responsible
From1 Jan 2017 → Today - Verstreken Lab (Research group)
Responsible
From1 Jan 2017 → Today - Department of Human Genetics (Department)
Member
From1 Apr 2009 → 31 Dec 2016
Projects
21 - 30 of 54
- Molecular and functional studies of the unconventional RabGAP TBC1D24, a protein that connects epilepsy to the regulation of synaptic functionFrom1 Jan 2017 → 31 Dec 2020Funding: FWO research project (including WEAVE projects)
- Targeting Tau-induced presynaptic pathology in Alzheimer’s diseaseFrom1 Aug 2016 → 31 Dec 2017Funding: FWO Strategic Basic Research Grant
- Regulation of the lipin phosphatidate phosphatase enzyme: a target for dystonia and metabolic disordersFrom1 Apr 2016 → 20 Apr 2021Funding: FWO Strategic Basic Research Grant
- Maintaining synaptic function for a healthy brain: Membrane trafficking and autophagy in neurodegenerationFrom1 Jan 2016 → 31 Dec 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Autophagy at synapses: proteopathic stress and neurodegeneration in Parkinson's diseaseFrom18 Nov 2015 → 28 Sep 2019Funding: FWO Strategic Basic Research Grant
- Protein turnover at synapses via autophagy: implications for Parkinson's diseaseFrom1 Sep 2015 → 19 Oct 2021Funding: FWO fellowships
- Dissecting the role of Parkinson's Disease related genes in the regulation of clock neurons and circadian rhythms.From1 Jan 2015 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
- Protein turn over at the synapse and the maintenance of robust neuronal communication.From1 Jan 2015 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
- Translating genetics of neurodegenerative disorders into therapeutic strategies.From1 Oct 2014 → 30 Sep 2021Funding: BOF - Methusalem
- An image storage platform for analysis management and mining.From10 Sep 2014 → 9 Mar 2019Funding: Hercules - Small and Medium size research infrastructure
Publications
1 - 10 of 146
- Neuronal identity defines a-synuclein and tau toxicity(2023)
Authors: Roman Praschberger, Natalie Kaempf, Eliana Nachman, Stein Aerts, Patrik Verstreken
- EndophilinA-dependent coupling between activity-induced calcium influx and synaptic autophagy is disrupted by a Parkinson-risk mutation(2023)
Authors: Marianna Decet, Lily Karamanou, Nikolaos Louros, Tassos Economou, Frederic Rousseau, Joost Schymkowitz, Patrik Verstreken
Pages: 1402 - + - Neurodegeneration cell per cell(2023)
Authors: Sriram Balusu, Bart De Strooper, Patrik Verstreken
Pages: 767 - 786 - Tyrosyl-tRNA synthetase has a noncanonical function in actin bundling(2023)
Authors: Patrick Callaerts, Patrik Verstreken
- Parkinsonism mutations in DNAJC6 cause lipid defects and neurodegeneration that are rescued by Synj1(2023)
Authors: Patrik Verstreken
- A reference human induced pluripotent stem cell line for collaborative studies(2022)
Authors: Patrik Verstreken
Pages: 1685 - + - Tau, synapses and brain disease(2022)
Authors: Pablo Largo Barrientos, Patrik Verstreken, Valerie Uytterhoeven
- Nano-positioning and tubulin conformation contribute to axonal transport regulation of mitochondria along microtubules(2022)
Authors: Marianna Decet, Tobie Martens, Patrik Verstreken, Pieter Vanden Berghe
- Do we still need animals? Surveying the role of animal-free models in Alzheimer's and Parkinson's disease research(2022)
Authors: Bart De Strooper, Patrik Verstreken
- Synaptic proteostasis in Parkinson's disease(2022)
Authors: Eliana Nachman, Patrik Verstreken
Pages: 72 - 79
Patents
1 - 10 of 10
- Screening method for synaptogyrin-3 inhibitors (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Means and methods for treatment of early-onset parkinson's disease (Inventor)
- Means and methods for treatment of early-onset parkinson's disease (Inventor)
- Compounds for treatment of intractable epilepsy and doors syndrome (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Compounds for treatment of intractable epilepsy and doors syndrome (Inventor)
- Restoring phosphorylation of a novel pink1 substrate to treat parkinson's disease (Inventor)
- Restoring phosphorylation of a novel pink1 substrate to treat parkinson's disease (Inventor)